Skip to main content
. 2021 May 21;11(6):332. doi: 10.3390/metabo11060332

Table 1.

Agents that modulate AKR1B10 expression.

Agent * Signal Molecule Cell ** References
Up-regulation
Ethoxyquin Nrf2 Lung cancer A549, H23 [14]
MG-132, bortezomib Nrf2 CRC SW-480, HT29 [17]
Doxorubicin Nrf2 Gastric cancer MKN45 [18]
EGF, insulin AP-1, ERK HCC HepG2, Hep3B [19]
Lipopolysaccharide Blood mononuclear cells [20]
BMP, IBMX Mesenchymal stem cells [21]
9,10-Phenanthrenequinone Nrf2, ERK Lung cancer A549 [22]
Cigarette smoke extract Airway epithelium [23]
Carnosic acid, t-BHQ Nrf2 Astrocytoma U373MG [15]
5-FU, L-OHP p53 CRC HT116 [16]
Down-regulation
TPA c-Jun, ERK Lung cancer A549 [15]
5-FU, L-OHP CRC HT29 [16]

Note: * Abbreviations of agents: EGF; epidermal growth factor, BMP, bone morphogenetic protein 2; IBMX, 3-isobutyl-1-methylxanthine; t-BHQ, t-butyl hydroquinone; 5-FU, 5-fluorouracil; L-OHP, oxaliplatin; TPA, 12-O-tetradecanoylphorbol 13-acetate. ** Abbreviations of cancer: CRC, colorectal cancer; HCC, hepatocellular cancer.